156
Participants
Start Date
July 31, 2024
Primary Completion Date
June 30, 2027
Study Completion Date
September 30, 2027
BB-031
Solution for injection
Placebo
0.9% sodium chloride for injection
RECRUITING
John Hunter Hospital, New Lambton Heights
RECRUITING
The Royal Melbourne Hospital, Parkville
RECRUITING
Monash Medical Centre, Clayton
RECRUITING
Princess Alexandra Hospital, Woolloongabba
RECRUITING
Royal Adelaide Hospital, Adelaide
RECRUITING
Fiona Stanley Hospital, Murdoch
NOT_YET_RECRUITING
WakeMed, Raleigh
RECRUITING
Baptist Health Medical Center, Jacksonville
RECRUITING
The Ohio State University, Columbus
RECRUITING
ProMedica Toledo Hospital, Toledo
RECRUITING
Henry Ford Hospital, Detroit
NOT_YET_RECRUITING
Valley Baptist Medical Center - Harlingen, Harlingen
ACTIVE_NOT_RECRUITING
HonorHealth Bob Bove Neuroscience Institute, Scottsdale
NOT_YET_RECRUITING
Providence Little Company of Mary Medical Center, Torrance
WITHDRAWN
MemorialCare Long Beach Medical Center, Long Beach
WITHDRAWN
Mills Peninsula Medical Center, Burlingame
WITHDRAWN
California Pacific Medical Center, San Francisco
RECRUITING
University of Calgary, Calgary
RECRUITING
University of Alberta Hospital, Edmonton
Lead Sponsor
Basking Biosciences, Inc.
INDUSTRY